Schedule 13G ownership disclosure
CELYAD SA
Security class unavailable · CUSIP: 151205200
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 968,847
- Percent of class
- 6.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001040188-21-000019
- Form type
- SC 13G
- Filer
- Celyad Oncology SA
- CIK
- CIK 1637890
- Filed
- Feb 02, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership